Seres therapeutics reports q1 2020 financial results and provides business updates

Seres therapeutics reports first quarter 2020 financial results and provides business updates.seres therapeutics inc - ended q1 with approximately $75.1 million in cash, cash equivalents and investments compared with $94.8 million at december 31, 2019.seres therapeutics inc qtrly loss per share $0.28.
MCRB Ratings Summary
MCRB Quant Ranking